Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment
Hepatocellular carcinoma (HCC) accounts for the majority of primary liver cancers and is the third leading cause of cancer-related mortality worldwide. Multifactorial drug resistance is regarded as the major cause of treatment failure in HCC. Accumulating evidence shows that the constituents of the...
Main Authors: | Jiaxin Zhang, Huiqiong Han, Lei Wang, Wenjia Wang, Mei Yang, Yanru Qin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.988956/full |
Similar Items
-
CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment
by: Yinjiang Zhang, et al.
Published: (2021-08-01) -
Prognostic and Therapeutic Role of Angiogenic Microenvironment in Thyroid Cancer
by: Assunta Melaccio, et al.
Published: (2021-06-01) -
Nanoparticle-Based Therapeutics to Overcome Obstacles in the Tumor Microenvironment of Hepatocellular Carcinoma
by: Yuanfei Lu, et al.
Published: (2022-08-01) -
Editorial: Therapeutic Opportunities and Innovative Biomarkers in Tumor Microenvironment
by: Kexin Xu, et al.
Published: (2021-11-01) -
The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
by: Betul Gok Yavuz, et al.
Published: (2023-10-01)